Loading clinical trials...

Immune Dysregulation in Hepatitis C Patients With or Without Arthritis | Clinical Trials | Clareo Health

UNKNOWNNCT01195987

Immune Dysregulation in Hepatitis C Patients With or Without Arthritis

The purpose of this study is to study the role of the Immune System in causing arthritis in patients with Hepatitis C.

Lead sponsor: The Center for Rheumatic Disease, Allergy, & Immunology•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Nabih I Abdou, MD, PhD

CONTACT

816-531-0930

Cindy A Greenwell, RN, BSN, CCRC

CONTACT

816-531-0930 cindy@centerforrheumatic.com

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment30

Start dateJun 2010

Last updatedSep 8, 2010

Condition

Hepatitis C Patients

Locations shown

Center for Rheumatic Disease, Allergy & Immunology

Kansas City, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2010Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions